PDS Biotechnology Corp
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2011 | — | — | $140.9K |
| Dec 2012 | — | $-7.7M | — |
| Dec 2013 | — | $-15.3M | $7.9M |
| Sep 2014 | — | — | $2.8M |
| Dec 2014 | — | $-27.8M | $13.7M |
| Mar 2015 | — | — | $12.3M |
| Jun 2015 | — | — | $58.5M |
| Sep 2015 | $6.0M | $-50.6M | $52.9M |
| Dec 2015 | $5.5M | $122.5M | $130.2M |
| Mar 2016 | $4.9M | $114.7M | $119.9M |
| Jun 2016 | $4.4M | $106.8M | $111.0M |
| Sep 2016 | $15.0M | $97.5M | $112.8M |
| Dec 2016 | — | $89.3M | $106.4M |
| Mar 2017 | — | $78.6M | $95.6M |
| Jun 2017 | — | $84.3M | $108.7M |
| Sep 2017 | — | $74.7M | $97.3M |
| Dec 2017 | — | $-609.5K | $88.1M |
| Mar 2018 | — | $-284.4K | $75.0M |
| Jun 2018 | — | $-807.6K | $46.0M |
| Sep 2018 | — | $-1.1M | $36.8M |
| Dec 2018 | — | $-2.1M | $103.7K |
| Mar 2019 | — | $24.4M | $26.6M |
| Jun 2019 | — | $20.6M | $21.7M |
| Sep 2019 | — | $15.6M | $17.4M |
| Dec 2019 | — | $11.7M | $12.2M |
| Mar 2020 | — | $19.9M | $21.0M |
| Jun 2020 | — | $17.0M | $16.9M |
| Sep 2020 | — | $31.0M | $33.5M |
| Dec 2020 | — | $27.1M | $28.8M |
| Mar 2021 | — | $24.4M | $25.0M |
| Jun 2021 | — | $73.0M | $74.7M |
| Sep 2021 | — | $67.9M | $69.7M |
| Dec 2021 | — | $63.2M | $65.2M |
| Mar 2022 | — | $55.9M | $58.9M |
| Jun 2022 | — | $51.4M | $53.0M |
| Sep 2022 | — | $47.1M | $71.6M |
| Dec 2022 | — | $44.0M | $73.8M |
| Mar 2023 | — | $41.0M | $65.2M |
| Jun 2023 | — | $32.4M | $60.6M |
| Sep 2023 | — | $24.5M | $54.3M |
| Dec 2023 | — | $26.1M | $56.6M |
| Mar 2024 | — | $37.2M | $66.6M |
| Jun 2024 | — | $30.9M | $57.7M |
| Sep 2024 | — | $22.0M | $49.8M |
| Dec 2024 | — | $19.0M | $41.7M |
| Mar 2025 | — | $22.4M | $40.0M |
| Jun 2025 | — | $16.0M | $31.9M |
| Sep 2025 | — | $9.5M | $26.2M |
| Dec 2025 | — | $9.3M | $26.7M |
| Mar 2026 | — | $3.9M | $21.7M |
| Jun 2026 | — | $-3.6M | $5.6M |